Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 2
2007 4
2008 2
2009 1
2010 1
2012 2
2013 2
2014 1
2015 2
2017 1
2018 3
2019 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Tablet formulation of Famotidine-loaded P-gp inhibiting nanoparticles using PLA-g-PEG grafted polymer.
Mokhtar M, Gosselin PM, François-Xavier L, Hildgen P. Mokhtar M, et al. Pharm Dev Technol. 2019 Feb;24(2):211-221. doi: 10.1080/10837450.2018.1455695. Epub 2018 Apr 4. Pharm Dev Technol. 2019. PMID: 29564944
Our work aimed at evaluating the use of permeability glycoprotein (P-gp) inhibiting nanoparticles (NPs) as a part of a suitable oral solid dosage to improve bioavailability. ...This could therefore represent an attractive formulation alternative to enhance oral permeabilit …
Our work aimed at evaluating the use of permeability glycoprotein (P-gp) inhibiting nanoparticles (NPs) as a part of a suitable oral …
Design of PEG-grafted-PLA nanoparticles as oral permeability enhancer for P-gp substrate drug model Famotidine.
Mokhtar M, Gosselin P, Lacasse F, Hildgen P. Mokhtar M, et al. J Microencapsul. 2017 Feb;34(1):91-103. doi: 10.1080/02652048.2017.1290155. J Microencapsul. 2017. PMID: 28151040
Bioavailability of oral drugs can be limited by an intestinal excretion process mediated by P-glycoprotein (P-gp). Polyethylene glycol (PEG) is a known P-gp inhibitor. ...NPs prepared from PLA-g-PEG5% are promising to improve oral bioavailability of P- …
Bioavailability of oral drugs can be limited by an intestinal excretion process mediated by P-glycoprotein (P-gp). Polyethylen …
Artificial neural network modeling for drug dialyzability prediction.
Daheb K, Lipman ML, Hildgen P, Roy JJ. Daheb K, et al. J Pharm Pharm Sci. 2013;16(5):665-75. doi: 10.18433/j35c8b. J Pharm Pharm Sci. 2013. PMID: 24393550 Free article.
The addition of BSA in the physiologic buffer statistically significantly decreased CLD for carvedilol (p= 0.002) and labetalol (p<0.001), but made no significant difference for atenolol (p= 0.100). In contrast, varying UFR does not significantly affect CL …
The addition of BSA in the physiologic buffer statistically significantly decreased CLD for carvedilol (p= 0.002) and labetalol (p …
Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study.
Derbali RM, Aoun V, Moussa G, Frei G, Tehrani SF, Del'Orto JC, Hildgen P, Roullin VG, Chain JL. Derbali RM, et al. Mol Pharm. 2019 May 6;16(5):1906-1916. doi: 10.1021/acs.molpharmaceut.8b01256. Epub 2019 Apr 4. Mol Pharm. 2019. PMID: 30900903
Despite their negative surface charge, liposomes still interacted with the P. aeruginosa membrane in a dose-response manner, as demonstrated by flow cytometry. ...Finally, nebulization of anionic liposomes containing levofloxacin did not impact their colloidal stability, a …
Despite their negative surface charge, liposomes still interacted with the P. aeruginosa membrane in a dose-response manner, as demon …
27 results